NeuBase Therapeutics, Inc. Common Stock

NBSE

...

NBSE: NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.

Show NBSE Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of NBSE by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by NBSE's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Modified peptide nucleic acid compositions Mar. 14, 2023

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on NBSE's company Twitter account

WallStreetBets

Number of mentions of NBSE in WallStreetBets Daily Discussion

NBSE News

Recent insights relating to NBSE

CNBC Recommendations

Recent picks made for NBSE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NBSE

Corporate Flights

Flights by private jets registered to NBSE